CIRINA

cirina-logo

Cirina is developing innovative blood-plasma tests to detect deadly diseases at their earliest stages when curative treatments are most viable. The company is driven by the passion and life-long work of Co-founder and plasma nucleic acid pioneer, Dennis Lo, the first scientist to discover the presence of fetal DNA in a pregnant motherโ€™s blood-plasma. Headquartered in South San Francisco, Calif., Cirina is currently actively recruiting top scientific and business talent to join its quest to detect devastating diseases like cancer at their earliest stages and empower people to take action. For more information, please visit http://cirinalabs.com.

#SimilarOrganizations #People #Financial #Website #More

CIRINA

Social Links:

Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical Medical Device

Founded:
2014-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.grail.com

Total Employee:
11+

Status:
Active

Contact:
415) 722-2129

Email Addresses:
[email protected]

Total Funding:
12 M USD

Technology used in webpage:
SPF IPv6 Google Apps For Business Google Google DNS Google Domains Google Cloud DNS


Similar Organizations

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Current Employees Featured

dennis-lo_image

Dennis Lo
Dennis Lo Co-Founder @ Cirina
Co-Founder

Founder


dennis-lo_image

Dennis Lo

Investors List

decheng-capital_image

Decheng Capital

Decheng Capital investment in Series A - Cirina

Official Site Inspections

http://www.grail.com

  • Host name: server-3-171-76-32.iad89.r.cloudfront.net
  • IP address: 3.171.76.32
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Cirina"

Who We Are - GRAIL

We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we โ€ฆSee details»

Grail - Crunchbase Company Profile & Funding

Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in โ€ฆSee details»

Grail (company) - Wikipedia

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. Grail was spun-out from Illumina on June 24, 2024. Their liquid biopsy (also called multi-cancer early detection test ) was launcheโ€ฆSee details»

GRAIL Information - RocketReach

GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and โ€ฆSee details»

GRAIL, Inc. (GRAL) Company Profile & Facts - Yahoo Finance

Description . GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals โ€ฆSee details»

GRAIL, Inc. (GRAL) Company Profile & Facts - Yahoo Finance

See the company profile for GRAIL, Inc. (GRAL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โ€ฆSee details»

Investor Relations - GRAIL, Inc.

GRAIL has made significant investments over time in technology, growth, and scalability, and we remain focused on our vision of multi-cancer early detection at the population level." Bob Ragusa. CEO. News Releases. All News Releases. โ€ฆSee details»

GRAIL, Inc. (GRAL) Company Profile & Overview - Stock โ€ฆ

5 days ago GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a โ€ฆSee details»

Environmental, Social and Governance - GRAIL, Inc.

GRAIL is focused on solving one of medicineโ€™s biggest healthcare challenges and pursuing a better way to help address the enormous toll that cancer has on patients, their families and society as a whole. ... (DEI) within our organization โ€ฆSee details»

Home - The Grail in the USA

The Grail in the US is a movement where all members are encouraged to advance our shared vision in the manner that best befits their interests, abilities and the needs of their community. We are individual threads that together โ€ฆSee details»

GRAIL, Inc - amga.org

If you are an organization that supports healthcare provider organizations, you can join as a Corporate Partner. Learn More. ... GRAIL is focused on alleviating the global burden of cancer โ€ฆSee details»

GRAIL Reports Second Quarter 2024 Financial Results and โ€ฆ

Jul 2, 2023 Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million. Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028. MENLO PARK, โ€ฆSee details»

GRAIL - Org chart - The Org

Explore GRAIL's organizational chart. Discover current team members including executives, board members, and advisors.See details»

The Grail Foundation of America

The Grail Foundation of America is a tax exempt not-for-profit organization which facilitates Grail activities within the USA. Founded in 1977, it acts as legal entity and asset holder for the Grail โ€ฆSee details»

Working At GRAIL: Company Overview and Culture - Zippia

Mar 14, 2024 We calculated GRAIL's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of GRAIL's workforce. GRAIL has 50 โ€ฆSee details»

Reflections on 2023 - GRAIL

Jan 5, 2024 2023 was an exciting year for GRAIL. We are seeing continued strong early adoption of Galleriโ“‡, our multi-cancer early detection (MCED) blood test, surpassing 150,000 โ€ฆSee details»

Grail CEO predicts โ€˜transformativeโ€™ 2024 amid Illumina split

Dec 19, 2023 Dive Brief: Grail has detailed its goals for 2024 after Illumina said that it will finally give up its fight with regulators to retain control of the liquid biopsy test maker it acquired two โ€ฆSee details»

GRAIL - Overview, News & Similar companies | ZoomInfo.com

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology Data Support Clinical Performance of Galleri to Detect โ€ฆSee details»

MedEd - GRAIL

Organization is appropriately firewalled from any affiliated sister or parent organization that provides strategy, marketing, or commercial services to GRAIL and its partners. Organization โ€ฆSee details»

linkstock.net © 2022. All rights reserved